SCHEMBL24944987

SCHEMBL24944987

CNc1nc(Nc2ccc(SC)cc2F)c(C(N)=O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAP2K2 P36507 2/20 0.41
▸ MAP2K1 Q02750 2/20 0.41
▸ ABCB11 O95342 1/20 0.33
▸ NQO2 P16083 1/20 0.33
▸ SYK P43405 1/20 0.32
▸ AURKA O14965 1/20 0.31
▸ CCNA2 P20248 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ PLK1 P53350 1/20 0.31
▸ CCNA1 P78396 1/20 0.31
▸ PLK3 Q9H4B4 1/20 0.31
▸ PLK2 Q9NYY3 1/20 0.31
▸ IKBKB O14920 1/20 0.30
▸ RET P07949 1/20 0.30
▸ ROS1 P08922 1/20 0.30
▸ FLT3 P36888 1/20 0.30
▸ EML4 Q9HC35 1/20 0.30
▸ ALK Q9UM73 1/20 0.30
▸ MAP4K1 Q92918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24944492 0.90 MAP2K2 (0.34) MAP2K2MAP2K1ABCB11NQO2SYK
SCHEMBL29173320 0.87 GPR119 (0.35) MAP2K2MAP2K1ABCB11NQO2CCNA2
SCHEMBL24944988 0.86 ABCB11 (0.33) MAP2K2MAP2K1ABCB11NQO2SYK
SCHEMBL24944491 0.85 ABCB11 (0.32) MAP2K2MAP2K1ABCB11NQO2SYK
SCHEMBL24944992 0.84 SYK (0.33) MAP2K2MAP2K1ABCB11NQO2SYK
SCHEMBL30205517 0.83 MAPK9 (0.48) MAP2K2SYKAURKACDK2PLK1
SCHEMBL24944367 0.83 MAPK9 (0.48) MAP2K2SYKAURKACDK2PLK1
SCHEMBL24944786 0.83 IKBKE (0.38) MAP2K2MAP2K1ABCB11NQO2RET
SCHEMBL24944783 0.82 LRRK2 (0.41) SYKAURKARETROS1FLT3
SCHEMBL24944998 0.80 EML4 (0.35) SYKRETROS1FLT3EML4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback